Outcome of Patients Treated With IABP

Outcome of Patients Treated With Intra Aortic Balloon Pump

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04405856

Enrollment

1000

Registered

2020-05-28

Start date

2012-02-01

Completion date

2025-12-31

Last updated

2020-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Cardiogenic Shock, Coronary Artery Disease, Heart Failure, Left Ventricular Dysfunction, Low Cardiac Output Syndrome, Post-cardiac Surgery

Brief summary

Intra-Aortic Balloon Pumps (IABP) is a widely used and effective left ventricular adjuvant therapy. IABP is an inflatable device placed in the aorta that inflates with diastole and deflates with systole. The aim of this study is to investigate the outcome of patients treated With IABP, and to evaluate the short-term and long-term outcomes of patients with IABP.

Interventions

DEVICEIntra Aortic Balloon Pump

Intra Aortic Balloon Pump (IABP) is a circulatory mechanical support device, placed in descending aorta, distally from left subclavian artery and proximally from renal artery. IABP works with counterpulsation concept, synchronized with heart cycle.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

1 Years to 100 Years

Inclusion criteria

* Patients receiving IABP for circulatory support

Exclusion criteria

* Refusal of consent

Design outcomes

Primary

Measure	Time frame
All-cause mortality	30 days after IABP implantation

Secondary

Measure	Time frame
All-cause mortality	3 months after IABP implantation

Countries

China

Contacts

Primary ContactHong Liu, MD

DR.HONGLIU@FOXMAIL.COM18801281613

Backup ContactYong-feng Shao, MD

yfshaojph@sina.com02568303100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026